FDAnews Announces Publication Dedicated to Genomics Industry

Posted on July 5, 2002

FDAnews announced its newest publication, Genomics Newswire, an independent publication providing reporting and analysis on the genomics industry. Published weekly online, Genomics Newswire covers current and emerging issues -- including new therapies in clinical trials, diagnostics, therapeutic cloning and stem cell research, agricultural biotechnology, nutraceutical developments, pharmacogenomics, drug discovery, target identification and validation.

"The deals that are being made now will lay the groundwork for the entire future of the genomics field," says Cynthia A. Carter, president of FDAnews, "and they're happening incredibly quickly. It's an all-out race to get products to market and recoup the R&D investment."

Genomics Newswire is published by FDAnews, publishers of Washington Drug Letter, Part 11 Compliance Report, Generic Line, Devices & Diagnostics Letter, Regulatory Watchdog Service, and other information services targeted at pharmaceutical, biotech and medical device executives.